those dying in hospital with obstructed airways had less severe non-respiratory injuries than those dying with clear airways. The same tendency could be discerned when the lowest 10% were considered, although the numbers of patients were very small. These results suggest strongly that airway obstruction contributes to the death of some patients in the first 72 hours of hospital care. They do not indict airway management in those who die before they reach hospital.
Discussion
This study is presented as much for its method as for its results. The introduction of the ISS will do much to help to measure performance that has hitherto been the subject of speculation. Improvement in the data retrieval systems available to accident units is, however, essential if full use is to be made of auditing techniques. Because no retrieval system was available this work was based on cumulative mortality rather than the much more satisfactory concept of mortality ratio. It follows that no observations could be made on the undoubtedly important role of airway management in the survivors.
The policy adopted for the prehospital care of accident victims remained constant throughout the five years under review . Ambulance crews were trained in basic resuscitation techniques and called out hospital staff only to care for trapped patients. The results would suggest that this quality of care is optimum with regard to airway management and that no improvement in survival could be expected if more advanced training were introduced. In contrast, airway management during the first 72 hours in hospital does not appear to be satisfactory.
These conclusions support the views of Hoffman,6 who suggested that more deaths could be prevented in hospital than at the roadside. More recently Rose et a17 have shown that a significant number of patients with head injury are dying unnecessarily in hospital. The work reported here has been concerned with only one aspect of the initial care of patients injured in an urban area. Outside the large conurbations more emphasis on prehospital treatment may be required because of the long distances involved. Such treatment will include the management of hypovolaemic shock and chest injuries, which were outside the scope of this review. All these aspects of initial care could and should be subjected to audit as methods for this are now available. between hypertensive and control subjects, but plasma noradrenaline seemed slightly increased in a proportion of hypertensive patients aged less than 50.
Plasma adrenaline was considerably raised in both supine and standing positions in eight patients with sustained liypertension and in two with labile hypertension. Dopamine concentrations and plasma renin activity were similar in all groups studied. The finding of significantly raised plasma adrenaline concentrations in a large proportion of hypertensive patients supports the hypothesis that the activity of the sympathetic nervous system is increased in essential hypertension. Measurement of plasma adrenaline seems to be a more sensitive index of this activity than that of plasma noradrenaline.
Introduction
The role of the sympathetic nervous system and the adrenal medulla in the pathogenesis of hypertension was first suspected many years ago when the effects of noradrenaline and adrenaline on stimulating contraction of vascular smooth muscle and accelerating the cardiac contraction rate were discovered. Doubt was cast on this hypothesis, however, by the inconsistency of early attempts to relate hypertension to abnormal urinary excretion of catecholamines.' The subsequent discovery that various potent hypotensive agents affect catecholamine metabolism led to a re-evaluation of the role of the sympathetic nervous system in hypertension. More 8 In most of these investigations, however, the difference between hypertensives and normotensives was slight, and the catecholamines measured in plasma were either noradrenaline alone or the sum of noradrenaline and adrenaline referred to as "total plasma catecholamines." The recent method of Da Prada and Zurcher9 permits a distinct and rapid estimation of noradrenaline, adrenaline, and dopamine in the same sample. We used this method to investigate the role of adrenaline, dopamine, and noradrenaline in essential hypertension.
Patients
Since plasma noradrenaline concentrations increase with age,'0 we studied hypertensive patients and controls with a similar mean age. Fifteen men and four women with essential hypertension, 18-63 years of age, were studied. Five of them were defined as having labile hypertension-that is, average casual blood-pressure readings of less than 160 mm Hg systolic or 95 mm Hg diastolic, or both. The 14 other patients had benign sustained high blood pressure according to fundal, cardiac, and renal examination. All were diagnosed as essential hypertensives as no cause of high blood pressure or associated disease was detected after a complete investigation. None had received any antihypertensive medication, and all of them were on a free diet. Of the control subjects, nine were men and two were women. They were aged between 26 and 76 years, and their blood pressure never exceeded 160/95 mm Hg on repeated measurements. Eight of them were students or scientists working in our laboratory. The older subjects were normotensive patients recovering from uterine haemorrhage, both supine and standing. No significant relation was found between systolic and diastolic blood pressures, heart rate, and the measured biochemical parameters. Plasma noradrenaline concentration increased with age in the overall population studied, in both supine and standing positions (fig 1) . Although the mean plasma noradrenaline value was the same in hypertensive and normotensive patients, it seemed (in agreement with Sever et al13) that noradrenaline concentrations tended to be higher in the group of hypertensive patients aged less than 50 years than in controls (fig 2) . In contrast with noradrenaline, plasma adrenaline in the normotensive group decreased with age in both supine and standing positions (fig 3) . No similar decrease with age was seen in hypertensive patients. In the hypertensive group plasma adrenaline values were often higher than those of controls, particularly in patients aged over 35. The rise of plasma adrenaline is also illustrated in fig 4, in which supine plasma adrenaline concentrations in controls and hypertensive patients were plotted against systolic pressure. Interestingly, when values of normotensive and hypertensive subjects were considered together, there was a positive correlation between plasma adrenaline and systolic blood pressure (r = 0 479; P < 0 01). A similar positive correlation was found for diastolic blood pressure (r = 0 376; P < 0 05). Plasma dopamine did not change with age and blood pressure. We found plasma renin activity to be identical in normotensive and hypertensive subjects; it was not influenced by age and did not seem to be correlated with plasma catecholamines.
Discussion
We found that supine and standing plasma noradrenaline concentrations increased with age, which agrees with previous reports.12 13 In disagreement with some investigators,4-8 but not others,'1 13 14 we did not find a statistically significant difference between mean plasma noradrenaline concentrations in normotensive and hypertensive subjects either at rest or on standing, although Sever et al 13 found a significant difference between controls and hypertensive patients aged less than 50. We also found that plasma noradrenaline concentrations in hypertensives aged less than 50 years tended to be higher. Interestingly, the percentage of hypertensives having plasma noradrenaline values above the range of controls values was approximately the same in our study as in that of Sever et al. ., .
Measurement of adrenaline concentrations gave more significant results. In normotensive subjects, plasma adrenaline tended to decrease with age, and the increment when standing was moderate. Plasma adrenaline concentrations were considerably raised in a significant number of patients with hypertension, either labile or sustained. The higher plasma adrenaline concentrations were mainly observed in hypertensive subjects over the age of 35. An increase in mean heart rate was observed in hypertensives, but no significant correlation was found between this and plasma adrenaline.
Few investigators have tried to measure circulating adrenaline. Engelman et al4 found that total plasma catecholamines were increased in hypertension without simultaneous variations in the noradrenaline:adrenaline ratio, which suggested an increase in plasma concentrations of adrenaline. Conversely, Pedersen and Christensen'4 and Esler et all5 reported no significant variation in plasma adrenaline concentrations between normotensive and hypertensive subjects. It is not easy to explain these contradictory results. It should be realised, however, that they were obtained with methods less sensitive than the radiometric assay used by us. Moreover, Esler et all5 studied young patients (aged less than 35 years), and our results seem to show that the rise in plasma adrenaline concentrations is more pronounced in older subjects.
The discrepancy between the results of measurements of plasma noradrenaline and adrenaline in hypertensives that we have observed may be interpreted in two ways. The first proposes that adrenaline released directly into the blood stream from the adrenal medulla is a direct index of splanchnic nerve activity. The second suggests that the amount of noradrenaline entering the blood, although reflecting the activity of peripheral sympathetic nerves,16 depends on many factors which may hamper the sensitivity of plasma noradrenaline measurements. These factors include neuronal release, reuptake into nerve terminals, extraneuronal tissue uptake, metabolism, and diffusion from the nerve endings to the lumen of the vessels.
Nevertheless, the more obvious increase in plasma adrenaline as compared with plasma noradrenaline may simply reflect an increase in sympathoadrenomedullary activity over general sympathetic activity. This is supported by various data from studies on animals. In DOCA-salt hypertension the conversion of radioactive tyrosine into catecholamines was found to be increased in the adrenal glands,17 and the amelioration of hypertension resulting from bilateral adrenalectomy showed that increased catecholamine synthesis might contribute to the maintenance of high blood pressure. Such a lowering effect was not observed in normotensive animals.18 Similarly, increased catecholamine content and rates of synthesis and secretion of catecholamines were found in adrenal glands of spontaneously hypertensive rats of the Japanese strain19 20; in these animals adrenalectomy seemed either to prevent the development of hypertension or to lower it, once established.21 22 The finding of an increased activity of the adrenal glands in human hypertension is consistent with the reduction of high blood pressure which has been indisputably observed in a significant, though not strictly defined, proportion of patients undergoing sympathectomy, splanchnicotomy, and partial adrenalectomy before oral preparations of antihypertensive drugs were available. Unlike adrenaline and noradrenaline, dopamine concentrations showed no change with posture, which supports the observation24 that plasma dopamine increases only with exhaustive exercise. Age did not influence plasma dopamine concentrations: these were similar in hypertensive and control subjects. No variation in plasma dopamine has been reported in other cases of altered adrenergic activity such as long fasting, or in neuroplegic patients.25 Thus circulating concentrations of this amine seem to be independent of sympathetic activity, and the physiological significance of dopamine in plasma has to be further investigated.
Renin release from the kidney may be regulated by the sympathetic nervous system in certain conditions.26 De Quattro and Miura 2 found a positive relation between plasma catecholamines and plasma renin activity. In agreement with Louis et al7 we found no such relation, indicating that renin secretion in hypertension is not entirely controlled by the sympathetic nervous system. Although our observations provide additional evidence implicating the sympathetic nervous system in hypertension, they do not indicate whether the increased nervous activity is a primary or secondary cause of the rise in blood pressure. They may, however, be useful in directing the choice of antihypertensive drugs. Patients with raised plasma concentrations of catecholamines may respond better to drugs acting through the nervous system. The clinical importance of labile hypertension is still debated. Some investigators2x think that it may lead to permanent hypertension. We found considerably raised concentrations of plasma adrenaline in two out of five patients with labile hypertension. It would be interesting to know whether the development of sustained hypertension is restricted to patients with increased plasma adrenaline concentrations.
